• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Role of calcium-blocking agents in treatment of cardiac arrhythmias related to myocardial ischemia.

作者信息

Surawicz B

出版信息

Am Heart J. 1982 Apr;103(4 Pt 2):698-706. doi: 10.1016/0002-8703(82)90476-8.

DOI:10.1016/0002-8703(82)90476-8
PMID:6278910
Abstract

Potential antiarrhythmic effects of calcium (slow-channel)-blocking drugs ca be indirect or direct. The indirect effect would affect ischemia-induced arrhythmias by improving myocardial perfusion or decreasing myocardial oxygen consumption. The direct effect would affect the electrical activity of the sinoatrial (SA) and atrioventricular (AV) nodes and any type of cardiac fibers depolarized to a level at which the slow inward current becomes activated. Although myocardial ischemia could become a setting of slow-channel-dependent conduction or automaticity, or both, there is no conclusive evidence that slow-channel-blocking drugs suppress ischemia-induced ventricular arrhythmias. Thus the principal usefulness of slow-channel-blocking drugs may be expected in the treatment of supraventricular arrhythmias and in the prevention of arrhythmogenic ischemia.

摘要

相似文献

1
Role of calcium-blocking agents in treatment of cardiac arrhythmias related to myocardial ischemia.
Am Heart J. 1982 Apr;103(4 Pt 2):698-706. doi: 10.1016/0002-8703(82)90476-8.
2
Acute coronary artery occlusion-reperfusion arrhythmias in pigs: antiarrhythmic and antifibrillatory evaluation of verapamil, nifedipine, prenylamine and propranolol.猪急性冠状动脉闭塞-再灌注心律失常:维拉帕米、硝苯地平、普尼拉明和普萘洛尔的抗心律失常及抗纤颤评估
Eur J Pharmacol. 1984 Jan 13;97(1-2):95-103. doi: 10.1016/0014-2999(84)90516-8.
3
[Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].[钙拮抗剂对缺血心肌中传导延迟的有利作用的潜在机制(作者译)]
Hokkaido Igaku Zasshi. 1981 May;56(3):335-45.
4
Anti-ischemic intervention as prognosis improvement in patients with coronary artery disease, with special focus on verapamil.抗缺血干预对冠心病患者预后的改善作用,特别关注维拉帕米。
Am J Cardiol. 1996 Jun 20;77(16):32D-36D. doi: 10.1016/s0002-9149(96)00306-2.
5
Use of calcium antagonists for cardiac arrhythmias.
Am J Cardiol. 1987 Jan 30;59(3):153B-162B. doi: 10.1016/0002-9149(87)90096-8.
6
Slow inward current and cardiac arrhythmias.缓慢内向电流与心律失常。
Am J Cardiol. 1985 Jan 25;55(3):89B-101B. doi: 10.1016/0002-9149(85)90617-4.
7
Calcium channel blockers and early ischemic ventricular arrhythmias: electrophysiological versus anti-ischemic effects.钙通道阻滞剂与早期缺血性室性心律失常:电生理效应与抗缺血效应
J Mol Cell Cardiol. 1987 May;19 Suppl 2:77-97. doi: 10.1016/s0022-2828(87)80006-8.
8
Mechanisms involved in reperfusion arrhythmias.再灌注心律失常的相关机制。
Eur Heart J. 1986 May;7 Suppl A:13-22.
9
Antiarrhythmic and anti-ischemic properties of calcium-channel antagonists.钙通道拮抗剂的抗心律失常和抗缺血特性。
New Horiz. 1996 Feb;4(1):45-57.
10
[Ion channels and arrhythmias].[离子通道与心律失常]
Z Kardiol. 2000;89 Suppl 3:6-12.

引用本文的文献

1
Delay by a calcium antagonist, amlodipine, of the onset of primary ventricular fibrillation in myocardial ischemia.钙拮抗剂氨氯地平延缓心肌缺血时原发性心室颤动的发生。
Cardiovasc Drugs Ther. 1996 Sep;10(4):447-54. doi: 10.1007/BF00051109.
2
Cardiac implications of amlodipine-dantrolene combinations.氨氯地平与丹曲林联合使用对心脏的影响。
Can J Anaesth. 1996 Jan;43(1):50-5. doi: 10.1007/BF03015958.
3
Attenuation of the ischaemia-induced fall of electrical ventricular fibrillation threshold by a calcium antagonist, diltiazem.
Naunyn Schmiedebergs Arch Pharmacol. 1993 Nov;348(5):509-14. doi: 10.1007/BF00173211.
4
Antiarrhythmic actions of verapamil against ischaemic arrhythmias in the rat.维拉帕米对大鼠缺血性心律失常的抗心律失常作用。
Br J Pharmacol. 1984 Oct;83(2):373-85. doi: 10.1111/j.1476-5381.1984.tb16497.x.